Finance

Lists
KURA:NASDAQ
Kura Oncology Inc
10,54 $
-3,21%
(-0,35) 1D
10,37 $
-1,61% (-0,17)
After hours
Closed: 22 հլս, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KURA...
Open
10,88 $
High
10,88 $
Low
10,47 $
Mkt. cap
935,68 մլն
Avg. vol.
1,67 մլն
Volume
0,00
52-wk high
12,49 $
52-wk low
5,45 $
EPS
-3,35 $
Beta
0,35
Shares outstanding
88,77 մլն
No. of employees
260
Open
10,88 $
High
10,88 $
Low
10,47 $
Mkt. cap
935,68 մլն
Avg. vol.
1,67 մլն
Volume
0,00
52-wk high
12,49 $
52-wk low
5,45 $
EPS
-3,35 $
Beta
0,35
Shares outstanding
88,77 մլն
No. of employees
260
News stories
From sources across the web
About Kura Oncology Inc
CEO-
Employees260
Founded2014
HeadquartersՍան Դիեգո, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 10 analysts giving stock ratings to KURA in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for KURA in the last 3 months.
Highest
Current 10,54 $
40,00 $ (+279,51%)
Average
28,11 $ (+166,70%)
Lowest
15,00 $ (+42,31%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Zemansky
Bank of America Securities
Buy
Maintained
30,00 $
+184,6%
07/22/2026
Etzer Darout
Barclays
Buy
Reiterated
28,00 $
+165,7%
07/20/2026
Salim Syed
Mizuho Securities
Buy
Maintained
25,00 $
+137,2%
06/23/2026
Unknown Analyst
Jefferies
Buy
Maintained
28,00 $
+165,7%
06/15/2026
Robert Driscoll
Wedbush
Buy
Reiterated
36,00 $
+241,6%
06/15/2026
Unknown Analyst
Wedbush
Buy
Reiterated
36,00 $
+241,6%
06/15/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
28,00 $
+165,7%
06/15/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
40,00 $
+279,5%
06/15/2026
Daniel Brims
Lake Street
Buy
Initiated
23,00 $
+118,2%
06/04/2026
David Dai
UBS
Buy
Maintained
15,00 $
+42,3%
06/03/2026
Unknown Analyst
Lake Street
Buy
Reiterated
23,00 $
+118,2%
05/13/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
05/12/2026
Unknown Analyst
Guggenheim
Hold
Maintained
-
-
03/06/2026
Last report
12 մյս, 2026 թ.
Fiscal period
Q1 2026
EPS / Est. (USD)
-0,83 $ / -0,78 $
-7,02%miss
Revenue / Est. (USD)
18,26 մլն / 25,92 մլն
-29,53%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
15,29 մլն
20,75 մլն
17,34 մլն
18,26 մլն
Cost of goods sold
62,78 մլն
67,91 մլն
64,46 մլն
65,52 մլն
Cost of revenue
62,78 մլն
67,91 մլն
64,46 մլն
65,52 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25,17 մլն
32,84 մլն
39,14 մլն
31,56 մլն
Operating expense
25,17 մլն
32,84 մլն
39,14 մլն
31,56 մլն
Total operating expenses
87,95 մլն
100,75 մլն
103,60 մլն
97,08 մլն
Operating income
-72,67 մլն
-80,00 մլն
-86,27 մլն
-78,82 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-66,12 մլն
-74,12 մլն
-80,93 մլն
-73,32 մլն
EBT excluding unusual items
-66,12 մլն
-74,12 մլն
-89,42 մլն
-73,32 մլն
Income tax expense
-
-
71,00 հզր
8,00 հզր
Effective tax rate
-
-
-0,09%
-0,01%
Other operating expenses
-
-
-
-
Net income
-66,12 մլն
-74,12 մլն
-81,00 մլն
-73,33 մլն
Net profit margin
-432,51%
-357,19%
-467,23%
-401,49%
Earnings per share
-0,75
-0,85
-0,92
-0,83
Interest and investment income
6,94 մլն
6,27 մլն
-
5,83 մլն
Interest expense
-391,00 հզր
-393,00 հզր
-3,15 մլն
-336,00 հզր
Net interest expenses
6,54 մլն
5,88 մլն
-3,15 մլն
5,49 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-72,44 մլն
-79,83 մլն
-85,86 մլն
-78,46 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more